3E0L05Z
3E0L05Z — Introduction of Adhesion Barrier into Pleural Cavity, Open Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduce Adhesion Barrier in Pleural Cav, Open
How 3E0L05Z is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- LBody partThe specific site
- 0ApproachHow the site was reached
- 5DeviceWhat was left in place, if anything
- ZQualifierA further distinction where one applies
Codes near 3E0L05Z
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E0K87ZIntroduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
- 3E0K8BZIntroduction of Anesthetic Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
- 3E0K8GCIntroduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
- 3E0K8HZIntroduction of Radioactive Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
- 3E0K8KZIntroduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
- 3E0K8NZIntroduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
- 3E0K8SFIntroduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
- 3E0K8TZIntroduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
- 3E0L05ZIntroduction of Adhesion Barrier into Pleural Cavity, Open Approach
- 3E0L304Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Percutaneous Approach
- 3E0L305Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach
- 3E0L30MIntroduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach
- 3E0L317Introduction of Other Thrombolytic into Pleural Cavity, Percutaneous Approach
- 3E0L328Introduction of Oxazolidinones into Pleural Cavity, Percutaneous Approach
- 3E0L329Introduction of Other Anti-infective into Pleural Cavity, Percutaneous Approach
- 3E0L33ZIntroduction of Anti-inflammatory into Pleural Cavity, Percutaneous Approach
- 3E0L35ZIntroduction of Adhesion Barrier into Pleural Cavity, Percutaneous Approach